I
Ioannis M. Zacharioudakis
Researcher at New York University
Publications - 63
Citations - 2038
Ioannis M. Zacharioudakis is an academic researcher from New York University. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 22, co-authored 55 publications receiving 1564 citations. Previous affiliations of Ioannis M. Zacharioudakis include Brown University & Rhode Island Hospital.
Papers
More filters
Journal ArticleDOI
T2 Magnetic Resonance Assay for the Rapid Diagnosis of Candidemia in Whole Blood: A Clinical Trial
Eleftherios Mylonakis,Cornelius J. Clancy,Luis Ostrosky-Zeichner,Kevin W. Garey,George Alangaden,Jose A. Vazquez,Jeffrey S. Groeger,Marc A. Judson,Yuka Marie Vinagre,Stephen O. Heard,Fainareti N. Zervou,Ioannis M. Zacharioudakis,Dimitrios P. Kontoyiannis,Peter G. Pappas +13 more
TL;DR: T2MR is the first fully automated technology that directly analyzes whole blood specimens to identify species without the need for prior isolation of Candida species, and represents a breakthrough shift into a new era of molecular diagnostics.
Journal ArticleDOI
Colonization With Toxinogenic C. difficile Upon Hospital Admission, and Risk of Infection: A Systematic Review and Meta-Analysis
Ioannis M. Zacharioudakis,Fainareti N. Zervou,Elina Eleftheria Pliakos,Panayiotis D. Ziakas,Eleftherios Mylonakis +4 more
TL;DR: Over 8% of admitted patients are carriers of toxinogenic C. difficile with an almost 6 times higher risk of infection, and the importance of preventive measures toward colonized patients is stressed.
Journal ArticleDOI
Outcomes Among HIV-Positive Patients Hospitalized With COVID-19.
Savannah Karmen-Tuohy,Philip M. Carlucci,Fainareti N. Zervou,Ioannis M. Zacharioudakis,Gabriel Rebick,Elizabeth Klein,Jenna Reich,Simon Jones,Joseph Rahimian +8 more
TL;DR: This research presents a novel probabilistic approach that allows us to assess the importance of knowing the carrier and removal status of canine coronavirus as a source of infection for other animals and also investigates its role in humans.
Journal ArticleDOI
Characteristics, Comorbidities, and Outcomes in a Multicenter Registry of Patients with HIV and Coronavirus Disease-19.
Dima Dandachi,Grant Geiger,Mary W Montgomery,Savannah Karmen-Tuohy,Mojgan Golzy,Annukka A.R. Antar,Josep M. Llibre,Maraya Camazine,Alberto Díaz-De Santiago,Philip M. Carlucci,Ioannis M. Zacharioudakis,Joseph Rahimian,Celestine N. Wanjalla,Jihad Slim,Folasade Arinze,Ann Marie Porreca Kratz,Joyce Jones,Shital M. Patel,Ellen Kitchell,Adero Francis,Manoj Ray,David E Koren,John W Baddley,Brannon Hill,Paul E. Sax,Jeremy Y. Chow +25 more
TL;DR: Severe clinical outcomes occurred commonly in PWH and COVID-19 and the risk for poor outcomes was higher in those with comorbidities and lower CD4 cell counts, despite HIV viral suppression.
Journal ArticleDOI
PCR in Diagnosis of Invasive Aspergillosis: a Meta-Analysis of Diagnostic Performance
Marios Arvanitis,Panayiotis D. Ziakas,Ioannis M. Zacharioudakis,Fainareti N. Zervou,Angela M. Caliendo,Eleftherios Mylonakis +5 more
TL;DR: The pooled diagnostic performance of whole-blood and serum PCR assays was moderate, with a sensitivity and specificity of 84% and 76% suggesting that a positive or negative result is unable, on its own, to confirm or exclude a suspected infection.